Comparison 27. Sensitivity analysis 7, excluding comparisons responsible for the high level of heterogeneity.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
27.1 Number of fallers ‐ cholinesterase inhibitor vs placebo	2	168	Risk Ratio (IV, Fixed, 95% CI)	1.03 [0.92, 1.16]
27.1.1 Rivastigmine vs placebo	1	130	Risk Ratio (IV, Fixed, 95% CI)	1.00 [0.87, 1.15]
27.1.2 Donepezil vs placebo	1	38	Risk Ratio (IV, Fixed, 95% CI)	1.13 [0.90, 1.40]
27.2 Rate of falls ‐ exercise and education vs control	1	196	Rate Ratio (IV, Random, 95% CI)	0.24 [0.10, 0.61]